{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:22:20Z","timestamp":1775618540097,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"DOI":"10.7759\/cureus.80576","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:16:56Z","timestamp":1741976216000},"source":"Crossref","is-referenced-by-count":2,"title":["Aspergillus fumigatus Bloodstream Infection in the Absence of Classic Risk Factors: Expanding the Spectrum of Invasive Aspergillosis"],"prefix":"10.7759","author":[{"given":"Marcos","family":"Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nismat","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Penikilapate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oladipo","family":"Alao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"Kousha M","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011, 20:156-74. 10.1183\/09059180.00001011","journal-title":"Eur Respir Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis DP","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, et al.. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010, 50:1091-100. 10.1086\/651263","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-013-0539-3","article-title":"SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients","volume":"42","author":"Montagna MT","year":"2014","unstructured":"Montagna MT, Lovero G, Coretti C, et al.. SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection. 2014, 42:141-51. 10.1007\/s15010-013-0539-3","journal-title":"Infection"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/513943","article-title":"Invasive aspergillosis","volume":"26","author":"Denning DW","year":"1998","unstructured":"Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998, 26:781-803; quiz 804-5. 10.1086\/513943","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/317452","article-title":"Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and adolescent spectrum of HIV disease project","volume":"31","author":"Holding KJ","year":"2000","unstructured":"Holding KJ, Dworkin MS, Wan PC, Hanson DL, Klevens RM, Jones JL, Sullivan PS. Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and adolescent spectrum of HIV disease project. Clin Infect Dis. 2000, 31:1253-7. 10.1086\/317452","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21488","article-title":"Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes","volume":"84","author":"Parody R","year":"2009","unstructured":"Parody R, Martino R, S\u00e1nchez F, Subir\u00e1 M, Hidalgo A, Sierra J. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. Am J Hematol. 2009, 84:571-8. 10.1002\/ajh.21488","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley JW","year":"2010","unstructured":"Baddley JW, Andes DR, Marr KA, et al.. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010, 50:1559-67. 10.1086\/652768","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2011.02816.x","article-title":"Endemic and opportunistic infections in Brazilian solid organ transplant recipients","volume":"16","author":"Batista MV","year":"2011","unstructured":"Batista MV, Pierrotti LC, Abdala E, et al.. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health. 2011, 16:1134-42. 10.1111\/j.1365-3156.2011.02816.x","journal-title":"Trop Med Int Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(03)00013-0","article-title":"Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus","volume":"46","author":"Torres HA","year":"2003","unstructured":"Torres HA, Rivero GA, Lewis RE, Hachem R, Raad II, Kontoyiannis DP. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2003, 46:25-8. 10.1016\/S0732-8893(03)00013-0","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12152","article-title":"Chronic pulmonary aspergillosis","volume":"57","author":"Schweer KE","year":"2014","unstructured":"Schweer KE, Bangard C, Hekmat K, Cornely OA. Chronic pulmonary aspergillosis. Mycoses. 2014, 57:257-70. 10.1111\/myc.12152","journal-title":"Mycoses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir485","article-title":"Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients","volume":"53","author":"Garcia-Vidal C","year":"2011","unstructured":"Garcia-Vidal C, Barba P, Arnan M, et al.. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011, 53:e16-19. 10.1093\/cid\/cir485","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767130-00001","article-title":"Changing epidemiology of rare mould infections","volume":"67","author":"Malani AN","year":"2007","unstructured":"Malani AN, Kauffman CA. Changing epidemiology of rare mould infections. Drugs. 2007, 67:1803-12. 10.2165\/00003495-200767130-00001","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning DW","year":"1996","unstructured":"Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996, 23:608-15. 10.1093\/clinids\/23.3.608","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene RE","year":"2007","unstructured":"Greene RE, Schlamm HT, Oestmann JW, et al.. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007, 44:373-9. 10.1086\/509917","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.178.6.1781395","article-title":"Pulmonary aspergillosis in immunocompetent hosts without underlying lesions of the lung: radiologic and pathologic findings","volume":"178","author":"Kang EY","year":"2002","unstructured":"Kang EY, Kim DH, Woo OH, Choi JA, Oh YW, Kim CH. Pulmonary aspergillosis in immunocompetent hosts without underlying lesions of the lung: radiologic and pathologic findings. AJR Am J Roentgenol. 2002, 178:1395-9. 10.2214\/ajr.178.6.1781395","journal-title":"AJR Am J Roentgenol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet A","year":"2006","unstructured":"Cornillet A, Camus C, Nimubona S, et al.. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006, 43:577-84. 10.1086\/505870","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh TJ","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, et al.. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008, 46:327-60. 10.1086\/525258","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/427752","article-title":"Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required","volume":"40","author":"Vigouroux S","year":"2005","unstructured":"Vigouroux S, Morin O, Moreau P, et al.. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis. 2005, 40:e35-7. 10.1086\/427752","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348883-aspergillus-fumigatus-bloodstream-infection-in-the-absence-of-classic-risk-factors-expanding-the-spectrum-of-invasive-aspergillosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:16:58Z","timestamp":1741976218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348883-aspergillus-fumigatus-bloodstream-infection-in-the-absence-of-classic-risk-factors-expanding-the-spectrum-of-invasive-aspergillosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.80576","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}